tiprankstipranks
Trending News
More News >
Agios Pharma (AGIO)
NASDAQ:AGIO
US Market
Advertisement

Agios Pharma (AGIO) Technical Analysis

Compare
639 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Agios Pharma’s (AGIO) Moving Averages Convergence Divergence (MACD) indicator is 0.35, suggesting Agios Pharma is a Sell.
Agios Pharma’s (AGIO) 20-Day exponential moving average is 37.56, while Agios Pharma’s (AGIO) share price is $37.71, making it a Buy.
Agios Pharma’s (AGIO) 50-Day exponential moving average is 36.63, while Agios Pharma’s (AGIO) share price is $37.71, making it a Buy.

Agios Pharma (AGIO) Pivot Points

Sep 01, 2025, 08:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
36.02
36.98
37.58
38.54
39.14
40.11
40.71
Fibonacci
36.98
37.58
37.95
38.54
39.14
39.51
40.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agios Pharma (AGIO) Moving Averages

Sep 01, 2025, 08:52 PM
Period
Simple
Exponential
MA5
38.18Sell
38.09Sell
MA10
37.84Sell
37.85Sell
MA20
37.10Buy
37.56Buy
MA50
37.09Buy
36.63Buy
MA100
33.64Buy
35.71Buy
MA200
35.98Buy
37.67Buy
Agios Pharma’s (AGIO) 10-Day exponential moving average is 37.85, while Agios Pharma’s (AGIO) share price is $37.71, making it a Sell.
Agios Pharma’s (AGIO) 100-Day exponential moving average is 35.71, while Agios Pharma’s (AGIO) share price is $37.71, making it a Buy.
Agios Pharma’s (AGIO) stock price is $37.71 and Agios Pharma’s (AGIO) 50-day simple moving average is 37.09, creating a Buy signal.
Agios Pharma’s (AGIO) stock price is $37.71 and Agios Pharma’s (AGIO) 100-day simple moving average is 33.64, creating a Buy signal.
Agios Pharma’s (AGIO) stock price is $37.71 and Agios Pharma’s (AGIO) 200-day simple moving average is 35.98, creating a Buy signal.

Agios Pharma (AGIO) Technical Indicators

Sep 01, 2025, 08:52 PM
Name
Value
Implied Action
RSI (14)
51.43
Neutral
STOCH (9,6)
59.01
Neutral
STOCHRSI (14)
67.03
Neutral
MACD (12,26)
0.35
Sell
ADX (14)
22.32
Neutral
Williams %R
-47.90
Buy
CCI (14)
68.70
Neutral
ATR (14)
1.75
-
Ultimate Oscillator
50.99
Neutral
ROC
7.50
Buy
Agios Pharma’s (AGIO) Relative Strength Index (RSI) is 51.43, creating a Neutral signal.
Agios Pharma’s (AGIO) Trend Strength Indicator (ADX) is 22.32, creating a Neutral signal.
Agios Pharma’s (AGIO) Commodity Channel Index (CCI) is 68.70, creating a Neutral signal.
Agios Pharma’s (AGIO) Price Rate of Change (ROC) is 7.50, creating a Buy signal.

FAQ

Is AGIO a Buy, Hold, or Sell?
Based on AGIO’s technical indicators, AGIO is a Buy.
    What is AGIO’s RSI (14)?
    AGIO’s RSI (14) is 51.43, which suggests AGIO is a Neutral.
      What is AGIO’s MACD?
      AGIO’s MACD is 0.35, which suggests AGIO is a Sell.
        What is AGIO’s 5-day moving average?
        AGIO’s 5-day moving average is 38.18, which suggests AGIO is a Sell.
          What is AGIO’s 20-day moving average?
          AGIO 20-day moving average is 37.10, which suggests AGIO is a Buy.
            What is AGIO’s 50-day moving average?
            AGIO’s 50-day moving average is 37.09, which suggests AGIO is a Buy.
              What is AGIO’s 200-day moving average?
              AGIO’s 200-day moving average is 35.98, which suggests AGIO is a Buy.
                What is AGIO’s Williams % R (14)?
                AGIO’s Williams % R (14) is -47.90, which suggests AGIO is a Buy.
                  What is AGIO’s CCI (14)?
                  AGIO’s CCI (14) is 68.70, which suggests AGIO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis